Peptides DB
Research-centric peptide and protocol reference hub

Research library

Every indexed study on every peptide in the database, with a machine summary and the numbers that matter pulled out. Filter on the left; the register updates as you go.

2255studies indexed1010with human data129registered trials1946carry a numeric findingLibrarian added 23 studies today
Showing 15 studiesSortNewest indexed
B
grade
Global, regional, and national burden of HIV/AIDS, 1990-2023, with the estimated burden attributable to intimate partner violence and forecasted impacts of funding cuts through 2030: results from the Global Burden of Disease Study 2023.
Bofanglutide · The lancet. HIV · 2026 · ReviewTop journal
The global HIV response has made progress but remains vulnerable to social factors and funding cuts, necessitating continued investment and integrated interventions.
2.06 million new HIV infections globally in 2023 (1.88-2.29 million).
A
grade
Assessing the Prognostic Value of Serial Seattle Angina Questionnaire Scores in Chronic Coronary Disease.
Bofanglutide · Circulation. Population health and outcomes · 2023 · RCT · Phase 4 · n=3405High-impact journal
Higher scores on the Seattle Angina Questionnaire are associated with a lower risk of cardiovascular events in patients with chronic coronary disease, suggesting that regular assessments could be beneficial.
Each 5-point increase in the current SAQ-SS was associated with a 7% lower risk of the primary endpoint (hazard ratio, 0.93 [95% CI, 0.90-0.96]).
A
grade
Safety, tolerability, relative bioavailability, pharmacokinetics, and pharmacodynamics of single and multiple doses of the novel oral bofanglutide in healthy Chinese participants.
Bofanglutide · Diabetes research and clinical practice · 2026 · RCT · Phase 1 · n=92
Oral bofanglutide showed low relative bioavailability and was well tolerated in healthy participants, but further studies are needed to assess its clinical utility.
Relative bioavailability was 0.56% for 30/60 mg and 1.31% for 90 mg.
C
grade
Time-resolved transcriptomics reveals mechanisms of acute and sustained low-pH adaptation in <i>Corynebacterium glutamicum</i>.
Bofanglutide · Synthetic and systems biotechnology · 2026 · Observational
Corynebacterium glutamicum shows a rapid loss of viability under acute low-pH shock, while sustained stress leads to a more gradual decline, highlighting the need for different strategies in strain engineering.
4.1-log10 decline in viability over 18 h under sustained stress.
B
grade
Integrating non-neonatal tetanus vaccination into an emergency department rabies PEP clinic: Real-world workload, documentation gaps, and VAERS-informed observation priorities.
Bofanglutide · Human vaccines & immunotherapeutics · 2026 · Observational · n=3365
The study highlights that 73.6% of animal-bite presentations in the ED are grade III exposures, emphasizing the need for improved documentation and routine tetanus vaccination availability.
Grade III exposures accounted for 73.6% of presentations.
Showing 15 of 15